Journals in Cancer

Cancer Pathogenesis and Therapy

ISSN: 2949-7132

Cancer Pathogenesis and Therapy (CPT) is an international open access journal covering key topics in all aspects of cancer research, focusing on mechanism innovation, emerging interdisciplinary and clinical trials research in Oncology. As a Chinese Medical Association (CMA) journal, it strives to publish the highest quality content that provides authoritative guidance to oncology specialists, physicians and researchers.CPT is dedicated to publishing innovative and significant research results in basic research, translation research and clinical oncology, including novel antitumor drugs, especially clinical trials, early screening/prevention, precise diagnosis and targeted therapy, interdisciplinary oncology innovation research and clinical translation in genetics, bioinformatics, pharmacology, and biology, and also new viewpoints, new ideas, new methods and new models of cancer prevention and public health policy.CPT regularly features news and expert interviews to promote expert oncologists' views on oncology guidelines, consensus , and education.CPT is concerned about, but not limited to, the following academic scopes: Basic Cancer Research, Clinical Cancer Research, Cancer prevention and public health policy, Oncological Pharmacology, Cancer Genomics, Cancer Informatics, Drug discovery, Artificial Intelligence, etc.The article types for CPT include: Research articles, Review article, Evidence-based Oncology, Clinical Trial, Editorial, Guideline and Consensus, Study Protocols, Mini review, Perspective, Case report, technical notes, Clinical Image, Letter to Editor, etc.P-ISSN 2097-2563

Clinical and Translational Radiation Oncology

ISSN: 2405-6308
5 Year impact factor: 3.3
Impact factor: 2.7

An Official Journal of The European Society for Radiotherapy and OncologyClinical and Translational Radiation Oncology is an international, open access journal which encompasses all aspects of clinical and translational radiation oncology research, particularly new developments in experimental radiobiology, clinical interventions and treatments. This includes imaging and biomarker studies with clinical endpoints, as well as research results from data sciences, epidemiology, and oncopolicy.The journal publishes original research articles, review articles, short communications, technical notes, case series and reports, and correspondence.For any information regarding Clinical and Translational Radiation Oncology please contact [email protected].

Current Problems in Cancer: Case Reports

ISSN: 2666-6219
5 Year impact factor: 0.2
Impact factor: 0.2

Current Problems in Cancer: Case Reports is an international, peer-reviewed open access Journal publishing oncology case reports. It aims to share awareness of groundbreaking cases that give insight into redefining concepts in cancer. Our topics are comprehensive, encompassing new understandings of cancer diagnosis, tumor biology, and treatment decisions. We also welcome tumor board reports which showcase multidisciplinary discussions of illustrative cases within a defined tumor group.A companion title to Current Problems in Cancer, the Journal provides a global forum for clinicians and researchers to share their personal experiences through case reports. We hope that academic and community physicians, providers, and students will participate and learn from this collection of case reports.

HPB

ISSN: 1365-182X
5 Year impact factor: 3.2
Impact factor: 2.7

To visit the HPB journal website click here: http://www.hpbonline.org/HPB is an international forum for clinical, scientific and educational communication.Twelve issues a year bring the reader leading articles, expert reviews, original articles, images, editorials, and reader correspondence encompassing all aspects of benign and malignant hepatobiliary disease and its management. HPB features relevant aspects of clinical and translational research and practice.Specific areas of interest include HPB diseases encountered globally by clinical practitioners in this specialist field of gastrointestinal surgery. The journal addresses the challenges faced in the management of cancer involving the liver, biliary system and pancreas. While surgical oncology represents a large part of HPB practice, submission of manuscripts relating to liver and pancreas transplantation, the treatment of benign conditions such as acute and chronic pancreatitis, and those relating to hepatobiliary infection and inflammation are also welcomed. There will be a focus on developing a multidisciplinary approach to diagnosis and treatment with endoscopic and laparoscopic approaches, radiological interventions and surgical techniques being strongly represented. HPB welcomes submission of manuscripts in all these areas and in scientific focused research that has clear clinical relevance to HPB surgical practice.HPB aims to help its readers - surgeons, physicians, radiologists and basic scientists - to develop their knowledge and practice. HPB will be of interest to specialists involved in the management of hepatobiliary and pancreatic disease however will also inform those working in related fields.Abstracted and Indexed in:MEDLINE®EMBASEPubMedScience Citation Index ExpandedAcademic Search (EBSCO)HPB is owned by the International Hepato-Pancreato-Biliary Association (IHPBA) and is also the official Journal of the American Hepato-Pancreato-Biliary Association (AHPBA), the Asian-Pacific Hepato Pancreatic Biliary Association (A-PHPBA) and the European-African Hepato-Pancreatic Biliary Association (E-AHPBA).

Journal of Bone Oncology

ISSN: 2212-1374
5 Year impact factor: 3.2
Impact factor: 3.1

Journal of Bone Oncology is an open access journal and is indexed in Clarivate Analytics' Journal Citation Reports/Science Edition as well as PubMedCentralThe Journal of Bone Oncology is a peer-reviewed international journal aimed at presenting basic, translational and clinical high-quality research related to bone and cancer.As the first journal dedicated to cancer induced bone diseases, JBO welcomes original research articles, review articles, editorials and opinion pieces. Case reports will only be considered in exceptional circumstances and only when accompanied by a comprehensive review of the subject.The areas covered by the journal include:Bone metastases (pathophysiology, epidemiology, diagnostics, clinical features, prevention, treatment)Preclinical models of metastasisBone microenvironment in cancer (stem cell, bone cell and cancer interactions)Bone targeted therapy (pharmacology, therapeutic targets, drug development, clinical trials, side-effects, outcome research, health economics)Cancer treatment induced bone loss (epidemiology, pathophysiology, prevention and management)Bone imaging (clinical and animal, skeletal interventional radiology)Bone biomarkers (clinical and translational applications)Radiotherapy and radio-isotopesSkeletal complicationsBone pain (mechanisms and management)Orthopaedic cancer surgeryPrimary bone tumoursClinical guidelinesMultidisciplinary careKeywords: bisphosphonate, bone, breast cancer, cancer, CTIBL, denosumab, metastasis, myeloma, osteoblast, osteoclast, osteooncology, osteo-oncology, prostate cancer, skeleton, tumour

Journal of Cancer Policy

ISSN: 2213-5383
5 Year impact factor: 1.5
Impact factor: 2

In affiliation with European Cancer Organisation Journal of Cancer Policy invites all readers to join the dedicated Twitter channel for the journal: https://twitter.com/jcan_policyThe Journal of Cancer Policy is an international journal which publishes research and reviews on global cancer policy. The journal encompasses all aspects of cancer policy from prevention and public health through all modalities of control and cure, palliative care and survivorship including:* Cancer systems and services research * Cancer economics and value-based care * Inequalities in access and outcomes of cancer care * Development and regulatory issues related to cancer drugs, radiotherapy and surgical technologies * Priorities for cancer policy development in low, middle and high income countries * Innovative strategies for prevention, screening and diagnosis of cancer * Development of cancer research and education infrastructure * Social determinants of cancer * The role of trade, globalisation and the law in cancer control * The role of the media and patient advocacy in cancer policy * Policy and social science research germane to cancer * Patient advocacy and information researchThe Journal of Cancer Policy will consider original research, reviews, short communications and reports, and correspondence for publication.

Journal of Geriatric Oncology

ISSN: 1879-4068
5 Year impact factor: 2.9
Impact factor: 3

The Journal of Geriatric Oncology is an international, multidisciplinary journal which is focused on advancing research in the treatment and survivorship issues of older adults with cancer, as well as literature relevant to education and policy development in geriatric oncology.Editor-in-Chief, Supriya Mohile, University of Rochester, USA and the Editorial Board invite you to submit a manuscript to the Journal of Geriatric Oncology. The journal welcomes the submission of manuscripts in the following categories:• Original research articles • Review articles • Clinical trials • Education and training articles • Short communications • Perspectives • Meeting reports • Letters to the EditorThe Journal of Geriatric Oncology is the official journal of the International Society of Geriatric Oncology (SIOG).Journal of Geriatric Oncology's Inclusion and Diversity Pledge This journal pledges to maintain diversity on the editorial team. This sits within Elsevier's broader?ongoing inclusion & diversity efforts. Equity and inclusion in publishing is critically important for scientific excellence and innovation. We believe passionately in the power of an inclusive publishing environment, not only to do what is right, but to enrich, strengthen and advance us all.

Neoplasia

ISSN: 1476-5586
5 Year impact factor: 5.4
Impact factor: 6.3

Neoplasia publishes the results of novel investigations in all areas of oncology research. The title Neoplasia was chosen to convey the journal’s breadth, which encompasses the traditional disciplines of cancer research as well as emerging fields and interdisciplinary investigations. Neoplasia is interested in studies describing new molecular and genetic findings relating to the neoplastic phenotype and in laboratory and clinical studies demonstrating creative applications of advances in the basic sciences to risk assessment, prognostic indications, detection, diagnosis, and treatment. In addition to regular Research Reports, Neoplasia also publishes Reviews and Meeting Reports. Neoplasia is committed to ensuring a thorough, fair, and rapid review and publication schedule to further its mission of serving both the scientific and clinical communities by disseminating important data and ideas in cancer research.Neoplasia encourages the free exchange of all clones, cell lines, and biological reagents described in its pages to facilitate the progress of research in order to ultimately provide those fighting neoplastic diseases with new diagnostic, preventative and therapeutic options.

Oral Oncology Reports

ISSN: 2772-9060

Oral Oncology Reports (OOR), a companion title to Oral Oncology , is an online-only, peer-reviewed, open access journal.OOR provides an international interdisciplinary forum for the rapid publication of research relating to biology, diagnosis and treatment of neoplasms of the head and neck.OOR publishes original research, clinical trials and review articles, editorials, and commentaries.OOR offers these benefits to authors:Fast and fair peer reviewRapid, article-based publicationUnrivalled visibility and exposure for your researchImmediate, free and permanent access to your paper on ScienceDirectImmediately citable using the article DOI

Pathology - Research and Practice

ISSN: 0344-0338
5 Year impact factor: 2.6
Impact factor: 2.9

Pathology - Research and Practice provides accessible coverage of the most recent developments across the entire field of pathology. The Journal publishes traditional morphological studies based on histopathology, including immunohistochemistry with clinical pathological correlations, if sound biostatistical data are provided. The submission of Case Reports is only encouraged for those that provide new information on the pathogenesis of the described disease based on additional molecular biological and genetic investigations. Timely reviews that focus on recent progress in pathology are highly encouraged.A main focus of Pathology - Research and Practice is publication of manuscripts from different clinical disciplines applying molecular genetic and biological techniques and focusing on innovative results, which improve the understanding of causal pathogenesis of human diseases. Investigations for better understanding of cancer diseases and new insights into molecular carcinogenesis, including translational biology of particular cancer entities, are welcome. In this context, manuscripts focusing on new molecular genetic results, but also functional molecular biological data based on cell culture investigations and animal experiments are encouraged. With this strategy, the Journal seeks to contribute to improved understandings of human disease mechanisms.

Life Sciences

Physical Sciences & Engineering

Social Sciences & Humanities

Health